Scott T. Megaffin
Algemeen Directeur bij Adiso Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Scott T. Megaffin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.
25
| Private Company | Miscellaneous Commercial Services | 25 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022.
3
| Holding Company | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Scott T. Megaffin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Treasurer Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| QHSLAB, INC. | Financial Conglomerates | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| GENVEC INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Pharmaceuticals: Major | Director/Board Member | |
| OPTINOSE, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The company is based in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Colgate University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Masters Business Admin | |
| Princeton University | College/University | Graduate Degree Graduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
| University College Dublin | College/University | Doctorate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Compliance Officer Chief Tech/Sci/R&D Officer | |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Zurich | College/University | Doctorate Degree | |
New Jersey Chamber of Commerce Foundation, Inc.
 New Jersey Chamber of Commerce Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services New Jersey Chamber of Commerce is a business advocacy organization that actively supports legislation, regulation and initiatives. The company is headquartered in Trenton, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Services to the Health Industry | Corporate Officer/Principal Director/Board Member | |
| American Society for Blood & Marrow Transplantation | Corporate Officer/Principal Director/Board Member | ||
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal | |
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Biotechnology | Director/Board Member | |
Chromocell Corp.
 Chromocell Corp. Miscellaneous Commercial ServicesCommercial Services Chromocell Corp. engages in the discovery and development of flavors and nutritional ingredients and therapeutic products. It specializes in different areas of taste sensations as well as aroma and fragrance enhancer discovery. The company was founded by Christian Kopfli and Kambiz Shekdar in 2002 and is headquartered in North Brunswick, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Columbia Law School | College/University | Graduate Degree | |
Covis Pharmaceuticals, Inc.
 Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Chief Operating Officer Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Founder | |
| BRIGHT MINDS BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| PASITHEA THERAPEUTICS CORP. | Pharmaceuticals: Major | Director/Board Member | |
| Pgi Drug Discovery LLC | Chief Executive Officer | ||
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CHROMOCELL THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Zwitserland | 3 |
| Israël | 2 |
| Ierland | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Health Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 137 |
| Corporate Officer/Principal | 96 |
| Independent Dir/Board Member | 33 |
| Chairman | 33 |
| Undergraduate Degree | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Sol Barer | 32 |
| John E. Osborn | 27 |
| Andrew Pecora | 25 |
| Jason Robert Dinges | 22 |
| Eric Floyd | 18 |
| Elizabeth Barrett | 14 |
| Christopher Schaber | 13 |
| Anthony Marucci | 13 |
| Joseph Leveque | 12 |
| Tal Zaks | 12 |
| Emer Leahy | 12 |
| Jeffrey Nau | 12 |
| Charles Reinhart | 12 |
| Will Lewis | 12 |
| Srdjan Stankovic | 11 |
- Beurs
- Insiders
- Scott T. Megaffin
- Bedrijfsconnecties
